Ryan Wong, MD
Nephrology · Tucson, AZNPI 1174910053
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 33.4% of the total. That places this record below the midpoint for nephrology clinicians in AZ, where the typical reported total is $2,217.
Across 7 payments — averaging $63.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$148
- Akebia Therapeutics Inc$127
- Sanofi$77
- Genentech, Inc.$26
- Genentech USA, Inc.$22
- Coherus Oncology, Inc.$22
- plus $20 from 1 others
Across 3 payments — averaging $2450.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$4K
- Novartis$3K
What the payments were for
- Food & beverage$442100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 1 | $148 |
| Akebia Therapeutics Inc | 1 | $127 |
| Sanofi | 1 | $77 |
| Genentech, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $22 |
| Coherus Oncology, Inc. | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vafseo$127
How this compares
$442 in reported general payments places this provider in the 20th percentile of 259 nephrology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GalafoldMigalastat Hcl | 16 | $496,769 |
| OzempicSemaglutide | 59 | $71,376 |
| RybelsusSemaglutide | 18 | $42,396 |
| FarxigaDapagliflozin Propanediol | 35 | $41,238 |
| JardianceEmpagliflozin | 21 | $33,161 |
| EliquisApixaban | 18 | $21,329 |
| KerendiaFinerenone | 15 | $14,044 |
| Sevelamer Carbonate | 19 | $6,266 |
| Potassium Citrate ErPotassium Citrate | 34 | $2,613 |
| Midodrine Hcl | 11 | $2,282 |
| Torsemide | 47 | $2,014 |
| Cinacalcet Hcl | 18 | $1,910 |
| Calcium Acetate | 11 | $1,704 |
| Bumetanide | 15 | $1,123 |
| Telmisartan | 41 | $1,048 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Tucson
- Aneesha ShettyTucson$34K
- David WhittmanTucson$13K
- Bijin ThajudeenTucson$7K
- Mindy JanTucson$7K
- Tausif ZarTucson$6K
- Vincent CampionTucson$5K
- Randy CooperPeoria$597K
- Minesh RajpalPeoria$403K
- Umar WaheedPeoria$150K
- Amer KhanPeoria$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.